Jasmine Cui, InnoCare CEO
August 17, 2021 07:21 AM EDTUpdated August 18, 11:45 AM
Deals
China

In­no­Care bags Chi­nese rights to In­cyte CAR-T ri­val Mon­ju­vi in bid to ex­pand in-house pipeline

Jason Mast

Editor

Mer­ck vet­er­an Jas­mine Cui has turned Bei­jing-based In­no­Care in­to a $4 bil­lion com­pa­ny large­ly on the strength of a sin­gle BTK in­hibitor and a clutch …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times